First Time Loading...

Heidelberg Pharma AG
XETRA:HPHA

Watchlist Manager
Heidelberg Pharma AG Logo
Heidelberg Pharma AG
XETRA:HPHA
Watchlist
Price: 2.98 EUR
Updated: May 6, 2024

Heidelberg Pharma AG
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Heidelberg Pharma AG
Cash from Financing Activities Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Heidelberg Pharma AG
XETRA:HPHA
Cash from Financing Activities
-€10.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Cash from Financing Activities
-€778.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Cash from Financing Activities
€43m
CAGR 3-Years
-64%
CAGR 5-Years
-25%
CAGR 10-Years
-11%
Immatics NV
NASDAQ:IMTX
Cash from Financing Activities
€84.5m
CAGR 3-Years
-26%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Cash from Financing Activities
-€6.8m
CAGR 3-Years
N/A
CAGR 5-Years
43%
CAGR 10-Years
N/A
Formycon AG
XETRA:FYB
Cash from Financing Activities
€40.7m
CAGR 3-Years
33%
CAGR 5-Years
46%
CAGR 10-Years
N/A

See Also

What is Heidelberg Pharma AG's Cash from Financing Activities?
Cash from Financing Activities
-10.1m EUR

Based on the financial report for Nov 30, 2023, Heidelberg Pharma AG's Cash from Financing Activities amounts to -10.1m EUR.